These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36744036)

  • 1. Inhalation of virus-loaded droplets as a clinically plausible pathway to deep lung infection.
    Chakravarty A; Panchagnula MV; Patankar NA
    Front Physiol; 2023; 14():1073165. PubMed ID: 36744036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.
    Chen PZ; Bobrovitz N; Premji Z; Koopmans M; Fisman DN; Gu FX
    Elife; 2021 Apr; 10():. PubMed ID: 33861198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Nasal and Lung Tissues Infected
    Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deposition distribution of the new coronavirus (SARS-CoV-2) in the human airways upon exposure to cough-generated droplets and aerosol particles.
    Madas BG; Füri P; Farkas Á; Nagy A; Czitrovszky A; Balásházy I; Schay GG; Horváth A
    Sci Rep; 2020 Dec; 10(1):22430. PubMed ID: 33384436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronavirus disease 2019 (COVID-19): research progress and clinical practice.
    Kutsuna S
    Glob Health Med; 2020 Apr; 2(2):78-88. PubMed ID: 33330782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influenza virus, SARS-CoV-2, and the airways: Clarification for the otorhinolaryngologist.
    de Gabory L; Alharbi A; Kérimian M; Lafon ME
    Eur Ann Otorhinolaryngol Head Neck Dis; 2020 Sep; 137(4):291-296. PubMed ID: 32507410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspective of the Relationship between the Susceptibility to Initial SARS-CoV-2 Infectivity and Optimal Nasal Conditioning of Inhaled Air.
    Ramasamy R
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Airborne Influenza A and SARS-CoV-2 Virus Shedding following Ocular Inoculation of Ferrets.
    Belser JA; Sun X; Kieran TJ; Brock N; Pulit-Penaloza JA; Pappas C; Basu Thakur P; Jones J; Wentworth DE; Zhou B; Tumpey TM; Maines TR
    J Virol; 2022 Dec; 96(24):e0140322. PubMed ID: 36448801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status.
    Neidleman J; Luo X; McGregor M; Xie G; Murray V; Greene WC; Lee SA; Roan NR
    Elife; 2021 Oct; 10():. PubMed ID: 34636722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational characterization of inhaled droplet transport to the nasopharynx.
    Basu S
    Sci Rep; 2021 Mar; 11(1):6652. PubMed ID: 33758241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily Viral Kinetics and Innate and Adaptive Immune Response Assessment in COVID-19: a Case Series.
    Vetter P; Eberhardt CS; Meyer B; Martinez Murillo PA; Torriani G; Pigny F; Lemeille S; Cordey S; Laubscher F; Vu DL; Calame A; Schibler M; Jacquerioz F; Blanchard-Rohner G; Siegrist CA; Kaiser L; Didierlaurent AM; Eckerle I
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33177214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multiscale multicellular spatiotemporal model of local influenza infection and immune response.
    Sego TJ; Mochan ED; Ermentrout GB; Glazier JA
    J Theor Biol; 2022 Jan; 532():110918. PubMed ID: 34592264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4
    Kim EH; Nguyen TQ; Casel MAB; Rollon R; Kim SM; Kim YI; Yu KM; Jang SG; Yang J; Poo H; Jung JU; Choi YK
    J Virol; 2022 Mar; 96(6):e0187321. PubMed ID: 35107382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling insights into SARS-CoV-2 respiratory tract infections prior to immune protection.
    Chen A; Wessler T; Daftari K; Hinton K; Boucher RC; Pickles R; Freeman R; Lai SK; Forest MG
    Biophys J; 2022 May; 121(9):1619-1631. PubMed ID: 35378080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung Aerosol Dynamics of Airborne Influenza A Virus-Laden Droplets and the Resultant Immune System Responses: An In Silico Study.
    Haghnegahdar A; Zhao J; Feng Y
    J Aerosol Sci; 2019 Aug; 134():34-55. PubMed ID: 31983771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Covid-19 and non-Covid-19 viruses, including influenza viruses, to determine the influence of intensive preventive measures in Japan.
    Hirotsu Y; Maejima M; Shibusawa M; Amemiya K; Nagakubo Y; Hosaka K; Sueki H; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
    J Clin Virol; 2020 Aug; 129():104543. PubMed ID: 32663787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza A(H1N1)pdm09 Virus but Not Respiratory Syncytial Virus Interferes with SARS-CoV-2 Replication during Sequential Infections in Human Nasal Epithelial Cells.
    Fage C; Hénaut M; Carbonneau J; Piret J; Boivin G
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.
    Hemmi T; Ainai A; Hashiguchi T; Tobiume M; Kanno T; Iwata-Yoshikawa N; Iida S; Sato Y; Miyamoto S; Ueno A; Sano K; Saito S; Shiwa-Sudo N; Nagata N; Tamura K; Suzuki R; Hasegawa H; Suzuki T
    Vaccine; 2022 Sep; 40(41):5892-5903. PubMed ID: 36064667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replication Kinetics, Cell Tropism, and Associated Immune Responses in SARS-CoV-2- and H5N1 Virus-Infected Human Induced Pluripotent Stem Cell-Derived Neural Models.
    Bauer L; Lendemeijer B; Leijten L; Embregts CWE; Rockx B; Kushner SA; de Vrij FMS; van Riel D
    mSphere; 2021 Jun; 6(3):e0027021. PubMed ID: 34160239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus.
    Ekanger CT; Zhou F; Bohan D; Lotsberg ML; Ramnefjell M; Hoareau L; Røsland GV; Lu N; Aanerud M; Gärtner F; Salminen PR; Bentsen M; Halvorsen T; Ræder H; Akslen LA; Langeland N; Cox R; Maury W; Stuhr LEB; Lorens JB; Engelsen AST
    Front Cell Infect Microbiol; 2022; 12():841447. PubMed ID: 35360113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.